Earnings ·
Establishment Labs raises full-year revenue guidance to $269M-$271M as Q2 sales rise 31.7% to $67.5M
ESTAEstablishment Labs Holdings Inc.
Establishment Labs Holdings Inc. reported second quarter 2026 financial results with revenue of $67.5 million, a 31.7% increase from the prior year period. The company raised its full-year revenue guidance to $269 million–$271 million from the previous range of $266.5 million–$268.5 million. Adjusted EBITDA turned positive at $3.7 million, compared to a loss of $8.5 million in the year-ago quarter, while net loss narrowed to $11.7 million from $16.6 million. Cash balances stood at $71.2 million as of June 30, 2026. Establishment Labs Holdings Inc. operates in the medical device industry, specializing in breast aesthetics and reconstruction solutions.